Pfizer’s updated COVID-19 vaccine approved by Health Canada – National

Pfizer’s updated COVID-19 vaccine approved by Health Canada – National

By Nicole Ireland and Hannah Alberga The Canadian Press Posted September 24, 2024 12:40 pm 1 min read Descrease article font size Increase article font size Health Canada has approved Pfizer-BioNTech’s updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus. The mRNA vaccine, called Comirnaty, targets the KP.2 … Read more

Vaccine misinformation ‘killed voters’ in Red states

Vaccine misinformation ‘killed voters’ in Red states

Kansas AG Kris Kobach: Pfizer violated state Consumer Protection Act Pfizer: Case has ‘no merit’ and company will respond in ‘due course’ Dr. John Moore: Political vaccine misinformation deadly to citizens Updated: Jun 20, 2024 / 09:45 PM CDT (NewsNation) – Dr. John Moore, Cornell University virologist and researcher, says “Red COVID” is a “statistically proven … Read more

Kansas AG sues Pfizer over alleged misrepresentation of COVID vaccine

Kansas AG sues Pfizer over alleged misrepresentation of COVID vaccine

(NewsNation) — The state of Kansas has sued the pharmaceutical company Pfizer, accusing it of misleading the public about its COVID-19 vaccine by making false claims about its effectiveness. In the lawsuit filed Monday, Republican Attorney General Kris Kobach claims Pfizer misled Kansas residents by claiming the vaccine was safe and hid evidence of the shot’s link … Read more

Sharekhan By BNP Paribas: 2 top stock picks from Foram Parekh for near term

Sharekhan By BNP Paribas: 2 top stock picks from Foram Parekh for near term

“In North America, Revlimid is the key contributor and again, speciality drugs for Zydus Lifesciences that will keep on increasing EBITDA margins towards 29-30% and also in the valuation-wise Zydus Life is not trading at much higher valuations like Sun, therefore we feel that Zydus Life is also a second stock which can see good … Read more

Pfizer Will Charge $1,390 For 1 Course Of COVID Drug Paxlovid On Commercial Market

Pfizer Will Charge ,390 For 1 Course Of COVID Drug Paxlovid On Commercial Market

At HuffPost, we believe that everyone needs high-quality journalism, but we understand that not everyone can afford to pay for expensive news subscriptions. That is why we are committed to providing deeply reported, carefully fact-checked news that is freely accessible to everyone. Our News, Politics and Culture teams invest time and care working on hard-hitting … Read more